Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal hypothyroidism: recognition and management.

G A Brent1

  • 1Endocrinology Division, West Los Angeles VA Medical Center, Los Angeles, California 90073, USA. gbrent@ucla.edu

Thyroid : Official Journal of the American Thyroid Association
|August 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid hormone receptor gene knockouts.

Trends in endocrinology and metabolism: TEM·2008
Same author

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.

Endocrine-related cancer·2006
Same author

Iodide sensitizes genetically modified non-small cell lung cancer cells to ionizing radiation.

Cancer gene therapy·2005
Same author

Thyroid hormone regulation of prohormone convertase 1 (PC1): regional expression in rat brain and in vitro characterization of negative thyroid hormone response elements.

Journal of molecular endocrinology·2004
Same author

Tissue-specific actions of thyroid hormone: insights from animal models.

Reviews in endocrine & metabolic disorders·2001
Same author

Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.

Cancer gene therapy·2001

Pregnant women with hypothyroidism often need higher thyroxine (T4) doses, especially in the first trimester. Adjusting T4 dosage during pregnancy requires careful monitoring due to metabolic changes.

Area of Science:

  • Endocrinology
  • Reproductive Medicine
  • Thyroid Disorders

Background:

  • Pregnancy can unmask or worsen hypothyroidism, particularly in women with early thyroid failure or iodine deficiency.
  • Existing hypothyroidism often necessitates increased thyroxine (T4) replacement therapy during gestation.
  • The exact mechanisms driving elevated T4 requirements in pregnancy remain unclear.

Purpose of the Study:

  • To investigate the changes in thyroxine (T4) dosage requirements during pregnancy for women with hypothyroidism.
  • To understand the temporal patterns and influencing factors of increased T4 needs throughout gestation.

Main Methods:

  • This study reviews the physiological changes in thyroid hormone metabolism during pregnancy.
  • It examines the typical T4 dose adjustments observed from the first trimester through postpartum.

Related Experiment Videos

  • The relationship between the etiology of hypothyroidism and the magnitude of T4 dose increase is considered.

    • Main Results:

    • An increased T4 dose requirement is commonly observed by the first trimester of pregnancy.
    • The T4 dose requirement tends to escalate throughout pregnancy and returns to pre-pregnancy levels after delivery.
    • The extent of the T4 dose increase is influenced by the underlying cause of hypothyroidism.

    Conclusions:

    • Pregnancy significantly alters thyroxine (T4) metabolism, leading to increased dosage needs in hypothyroid women.
    • Close monitoring and timely T4 dose adjustments are crucial for managing hypothyroidism during pregnancy.
    • The etiology of hypothyroidism plays a role in determining the degree of T4 requirement changes during gestation.